Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.
about
Newer gene editing technologies toward HIV gene therapyModeling Viral Infectious Diseases and Development of Antiviral Therapies Using Human Induced Pluripotent Stem Cell-Derived SystemsBone Marrow Gene Therapy for HIV/AIDSGenetically modified hematopoietic stem cell transplantation for HIV-1-infected patients: can we achieve a cure?Engineering T Cells to Functionally Cure HIV-1 InfectionAdvancements in Developing Strategies for Sterilizing and Functional HIV Cures.Genome-Edited T Cell Therapies.RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.Damaging the Integrated HIV Proviral DNA with TALENs.In vivo disruption of latent HSV by designer endonuclease therapyRNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection.Designed transcription activator-like effector proteins efficiently induced the expression of latent HIV-1 in latently infected cells.The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNAHIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a CureA high excision potential of TALENs for integrated DNA of HIV-based lentiviral vectorGenome editing strategies: potential tools for eradicating HIV-1/AIDS.Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA.Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors.Zinc Finger Nuclease: A New Approach to Overcome Beta-Lactam Antibiotic Resistance.Combined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid AssemblyThe therapeutic application of CRISPR/Cas9 technologies for HIV.Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.CRISPR-mediated Activation of Latent HIV-1 ExpressionSpecific Reactivation of Latent HIV-1 by dCas9-SunTag-VP64-mediated Guide RNA Targeting the HIV-1 Promoter.The clinical applications of genome editing in HIV.The variances of Sp1 and NF-κB elements correlate with the greater capacity of Chinese HIV-1 B'-LTR for driving gene expression.HIV-1 Latency and Eradication: Past, Present and FutureNaf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.Experimental Approaches for Eliminating Latent HIV.Specific and Stable Suppression of HIV Provirus Expression In Vitro by Chimeric Zinc Finger DNA Methyltransferase 1.DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.Potential mechanisms for cell-based gene therapy to treat HIV/AIDS.Application of gene-editing technologies to HIV-1.A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.Cell and gene therapy strategies to eradicate HIV reservoirsStem cell-based therapies for HIV/AIDS.Connecting HIV-1 integration and transcription: a step toward new treatments.A comprehensive overview of computational resources to aid in precision genome editing with engineered nucleases.
P2860
Q24631042-8B87873B-615C-4301-A4B2-03A2F0C616E7Q26799933-62058A66-0032-4C29-A7EB-6C9037DBF633Q26801765-4C384105-87EF-4BD6-9E03-10C1F9F60B1EQ26995220-1E88C848-739E-4027-9120-C8BBCCADD0D4Q28086801-32FDE43A-2323-49BB-8AEE-AB1EBBB0E32EQ33654409-DE21F836-5D9C-4EEE-A1D8-3AE920F697A0Q33729598-B5DC39FA-7F92-46E0-93BE-81396EEA1635Q34025414-1F90D695-4FC3-4449-96E2-EFDF64573C7AQ34475249-7FD7B8B9-AD77-4B96-9168-7DA90BF0644CQ34540648-954FAF89-53FE-4B53-B319-AAB7628A1AC4Q34583415-0D6EC743-EEE8-4D3B-8122-92A9DAD415B3Q34870253-30EC93A5-F2A3-45DD-AC87-38A75EFCFE92Q35177829-338B0709-E9B4-436F-9DD7-42509269252CQ35447267-3D233E32-778A-4C23-89C5-0773D4A14B8BQ35579568-7689DC26-0535-497E-9833-DF111F61C372Q35612053-26702D6C-F11D-4AC4-BF21-BC29C6E4EAE8Q35615234-D250BB20-F885-4497-80BF-81A2C8E19624Q35942658-FD8E93F6-C053-4921-859B-1DA1CC263749Q35995546-BECAE795-5A0B-4850-B95F-314A3FC35E64Q36030091-4FF97300-1FC5-4449-A974-7E2B1A4552E7Q36089328-8DD7759E-6F15-4BEA-9DCC-C7B4DBEF7AA8Q36181852-BCFD38C5-D4AE-4C44-86B0-21AF8400B49CQ36494284-6B90AF95-1350-4123-83D4-906278AF9A6CQ36675297-125B4488-9155-4F71-BC5C-772805E104D7Q36675349-E8F91D6E-8827-4128-8F64-7678E6F49DFEQ36942032-76BF1684-BA72-49EC-A435-5C30E9FFAFFBQ37307353-D8B65D84-DCB8-414D-B405-619829FA84E3Q37505823-632FAAE6-DC3B-4CCF-B5AE-6FE91FEF4D13Q37512889-77DC92BE-E6C8-4FCE-8C45-7735B4665C5CQ37596293-52F1A55C-B003-4871-AFC4-85979AB7C0A8Q37636531-F65B39F2-CDF4-4EAD-8EEB-634297029D8FQ37718212-26E23AF5-A8D2-466B-BBC3-5D676346E8EBQ38184158-1464C9E3-7CA0-49E1-A1F3-0C64BC103BD0Q38267240-030272AB-8DE8-4509-B024-829DE03CB937Q38328699-6525FD2D-4AD0-4067-BFC8-868C82C25E6EQ38759997-EF49661F-83C2-46A3-ACA4-1A00A2BC55C5Q38794293-EC1DBDAD-45D6-43F7-8732-921D33AB876EQ38827119-E3A5130E-0790-4308-BAC0-7330924B8705Q38844141-7594D14F-0C62-4D57-85F8-15A817D8F392Q38884774-DDC5F71D-3234-4668-B524-500AB216081B
P2860
Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@en
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@nl
type
label
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@en
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@nl
prefLabel
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@en
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@nl
P2093
P2860
P356
P1476
Zinc-finger-nucleases mediate ...... tently infected human T cells.
@en
P2093
Donglin Ding
Gongmin Zhang
Haibo Wang
Huanzhang Zhu
Jianhua Wang
Shaohui Liu
P2860
P304
P356
10.1093/NAR/GKT571
P407
P577
2013-06-26T00:00:00Z